News | ECG Monitoring Services | September 10, 2015

AliveCor Mobile ECG Shows Momentum as Tool for AFib Detection

AliveCor reports 30 percent of users have received an AFib detection that may otherwise have gone undiagnosed

AliveCor Mobile ECG, AFib, detection, atrial fibrillation

AliveCor Mobile ECG image courtesy of AliveCor

September 10, 2015 — AliveCor Inc. announced significant milestones related to patients with atrial fibrillation (AFib) using the AliveCor Mobile ECG. Since receiving the first U.S. Food and Drug Administration (FDA) clearance for the AF Detector, an algorithm to detect atrial fibrillation in an ECG (electrocardiogram), 30 percent of AliveCor patients have received an AFib detection. Additionally, more than 50 percent of U.S. users with an AFib detection received that detection within one week of their first AliveCor ECG recording, and close to 80 percent received it within one month.

September is AFib Awareness Month in the United States, which was started in 2009 by the Heart Rhythm Society in an effort to raise awareness of the increased prevalence of the disease and the associated risk of stroke in AFib patients. AFib is the most common cardiac arrhythmia and increases the risk of stroke up to five times. AFib can be hard to detect, as symptoms, including heart palpitations, may be mild or non-existent. The ability to automatically detect AFib using mobile technology like the AliveCor Mobile ECG has now proven to be an effective and important step in the detection of AFib so physicians can intervene before potentially life-threatening conditions, like strokes, occur.

"Atrial fibrillation is the most common arrhythmia in the United States. It can be challenging to detect, as almost 50 percent of patients are asymptomatic, until they develop a stroke or heart failure, which can be devastating. Being able to diagnose AFib before the development of complications has the potential to significantly improve the lives of numerous people," said Richard Wong, M.D., FACC, adult cardiologist, Kaiser Permanente Medical Group. "Having a mobile ECG monitoring device like the AliveCor Mobile ECG has been extremely helpful for me in my practice, specifically when screening for this potentially life-threatening arrhythmia."

An important step in AFib management is to understand a patient's lifestyle, daily activities and symptoms. The AliveECG app includes the Heart Journal, a feature that allows users to log daily activities, tag symptoms and events in real-time that can impact heart health and work to identify abnormalities. As this information is tracked alongside ECGs, both the patient and the treating physician have a more comprehensive picture of how the heart behaves under everyday conditions. Currently, 63 percent of U.S. users have tagged their ECGs in their Heart Journal.

"AliveCor's Heart Journal has been a helpful and easy way for me to learn about what is going on with my own heart by tracking my activities. Now, I do not have to try and remember what to tell my physician as I can easily share my notes and logs, and we can review the information together," said Linda Jankovic, an AliveCor user since June 2015.

AliveCor has seen tremendous growth throughout the past four years including expanded regulatory clearances, the launch of three algorithms, and adding almost 4 million AliveCor ECGs recorded into the AliveCor database. Additionally, the company has more than doubled the number of regular users and recordings in the last year and continues to expand globally, having entered nine new countries in 2015.

For more information: www.alivecor.com

Related Content

The QT Medical PCA 500 12-lead ECG system uses a unique wearable wrap that contains all the leads and eliminated the need to connect separate wire electrodes to the patient. The simplicfication of lead placement enables the system to be used by patients at home.

The QT Medical PCA 500 12-lead ECG system uses a unique wearable wrap that contains all the leads and eliminated the need to connect separate wire electrodes to the patient. The simplicfication of lead placement enables the system to be used by patients at home.

News | ECG | February 16, 2021
February 16, 2021 — QT Medical recently announced the launch of Xpress ECG service, the world’s first 12-lead ECG hom
There has been an increasing trend in cardiology to use longer term remote monitoring wearable ECG tracking devices. This is an example of of the Cardiac Insight Cardea Solo adhesive patch device.

There has been an increasing trend in cardiology to use longer term remote monitoring wearable ECG tracking devices. This is an example of of the Cardiac Insight Cardea Solo adhesive patch device.

News | ECG | February 02, 2021
February 2, 2021 — Cardiac Insight, Inc.
HeartSciences has been developing a new type of ECG system called Wavelet ECG that may offer a new way of looking at the heart. The MyoVista system uses continuous wavelet transform (CWT) signal processing to provide new frequency and energy information to detect cardiac relaxation abnormalities associated with left ventricular diastolic dysfunction commonly associated with hypertension, diabetes, valvular disease, ischemia, and reduced systolic function. Artificial intelligence is used to read the exam.

HeartSciences has been developing a new type of ECG system called Wavelet ECG that may offer a new way of looking at the heart. The MyoVista system uses continuous wavelet transform (CWT) signal processing to provide new frequency and energy information to detect cardiac relaxation abnormalities associated with left ventricular diastolic dysfunction commonly associated with hypertension, diabetes, valvular disease, ischemia and reduced systolic function. Artificial intelligence is used to read the nuances of these complex waveforms.

Feature | ECG | January 20, 2021 | By Dave Fornell, Editor
Here are a few trends to watch for in electrocardiogram (ECG, or if you prefer the original German EKG) systems.
OTC ECG devices

OTC ECG devices can help detect abnormal heart rhythms in the general population, and this technology will continue to improve.

Feature | ECG | March 11, 2020
Apple created a stir when it...
Several wearable, less-obtrusive ECG monitors fhave been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device. 

Several wearable, less-obtrusive ECG monitors have been cleared by the FDA for longer wear. This example is Cardiac Insight’s Cardea SOLO device. 

Feature | ECG | February 19, 2020
When the patients of Michael Boler, M.D. need cardiac monitoring, the Holter monitor is no longer his first choice. “...
The Bittium Faros uses a 4-in-1 ECG technology. It is a lightweight, waterproof and can be configured for different patient monitoring needs. Bittium Faros Holter monitoring.

The Bittium Faros uses a 4-in-1 ECG technology. It is a lightweight, waterproof and can be configured for different patient monitoring needs. 
 

News | ECG | January 22, 2020
January 22, 2020 – Bittium is exhibiting solutions for cardiology at...
Cardiologs
News | ECG | December 12, 2019
December 12, 2019 — Cardiologs, a global leader in artificial intelligence (AI)
FDA Clears AliveCor's KardiaMobile 6L as First Six-Lead Personal ECG Device
Technology | ECG | May 13, 2019
AliveCor announced its third U.S. Food and Drug Administration (FDA) clearance in three months, making KardiaMobile 6L...
One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

One innovation in ECG is its use in the customer wearable market, which will tie more closely into the clinical world either with using the data to triage patients and/or patients seeking medical attention prior to acute symptoms appearing.

Feature | ECG | May 03, 2019 | Sanket Solanki
Technology has made its way into the healthcare sector and brought a drastic transformation.
Videos | ECG | March 05, 2019
This is a quick demo of the Schiller Cardiovit FT-1 electrocardiograph (ECG) system displayed at the ...